Physicians should encourage pharmaceutical companies to make socially responsible funding decisions and take an active role in setting biomedical research priorities by advocating for fair and effective allocations of public and private biomedical R & D investments.
A Canadian physician reports there is systematic bias to the outcome of published research funded by the pharmaceutical industry and believes more steps need to be taken to improve the integrity of clinical research reports in the United States and Canada.
Prashasti Bhatnagar joins Ethics Talk to discuss her article, coauthored with Dr Deborah F. Perry and Margaret E. Greer: “How Should We Measure Effectiveness of Medical-Legal Partnerships?”
Dr Cynthia Geppert joins Ethics Talk to discuss her article: “How Should MLP Clinicians and Attorneys Help Veterans Secure Disability Benefits When Health Records Documentation Is Insufficient?”